Rare diseases affect one in 17 people in the UK, but a Government initiative designed to improve their quality of life will ...

DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von ...

Plasma medicine helped her to have a family after she developed a blood disorder. Danielle had immune thrombocytopenic purpura (ITP) – her immune system destroyed her platelets, the cell ...

NHS patients around the country are now receiving a lifesaving medicine made from the plasma of blood donors in Cambridgeshire. It marks the first time in a quarter of a century that the plasma is ...

NHS Blood and Transplant say that over the past two years, blood donors in Cambridgeshire have supplied iin the region of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, and rising demand for targeted therapies in hematology ...

Berikut adalah penjelasan tentang tips dan cara menaikkan trombosit pada anak, makanan yang harus dihindari, serta supplemen ...

A remarkable man has shared his battle with a rare blood disorder impacting 6,000 people in the UK. Anthony Heard from Lower Earley was diagnosed with Immune Thrombocytopenia (ITP) 19 year's ago ...

In my experience, the hardest aspect of my ITP diagnosis was wrapping my head around the fact that they had no idea how it came about and there was no cure for it. Imagine hearing that you have a rare ...

Individual patient factors, such as anemia and newly diagnosed ITP, as well as higher-risk procedures, increase the risk of post-procedure bleeding. The risk of bleeding after surgery in patients with ...